Qube Research & Technologies LTD Zynerba Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.33 - $1.39 $33 - $139	100 New	100 $0
Q3 2021 Nov 12, 2021	SELL	$3.72 - $5.35 $85,853 - $123,472	-23,079 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.83 - $5.98 $88,392 - $138,012	23,079 New	23,079 $122,000
Q1 2021 May 14, 2021	SELL	$3.33 - $8.76 $87,668 - $230,624	-26,327 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $32,078 - $45,518	9,810 Added 59.39%	26,327 $87,000
Q3 2020 Nov 12, 2020	SELL	$3.23 - $4.3 $22,299 - $29,687	-6,904 Reduced 29.48%	16,517 $55,000
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $77,523 - $153,173	23,421 New	23,421 $79,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.